| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| LM11A-31 | LM11A-31; LM11A-31-BHS | Phase 2 Clinical | Pharmatrophix Inc | Alzheimer Disease; Supranuclear Palsy, Progressive | Details |
| Recombinant human nerve growth factor (Xintrum Pharmacouticals) | rh-NGF; ZX1305; ZX-1305; ZX1305E; ZX-1305-E | Phase 2 Clinical | Jiangsu Zhongxin Pharmaceutical Co Ltd | Glaucoma, Open-Angle; Keratitis; Optic Nerve Injuries | Details |
| Recombinant Human Nerve Growth Factor (Kerun Biopharmaceutical) | Phase 1 Clinical | Chongqing Kerun Biologic Pharmaceutical Development Co Ltd | Keratitis; Xerophthalmia | Details |